.png "American Renal Associates Holdings Inc (NYSE: ARA)")
SunTrust Robinson analyst David S Macdonald reiterated a Buy rating on American Renal Associates Holdings Inc (ARA) today and set a price target of $16. The company’s shares opened today at $11.67, close to its 52-week low of $11.09.
According to TipRanks.com, Macdonald is a 5-star analyst with an average return of 12.0% and a 62.3% success rate. Macdonald covers the Services sector, focusing on stocks such as Fresenius Medical Care Corp, Walgreens Boots Alliance, and Quest Diagnostics Inc.
American Renal Associates Holdings Inc has an analyst consensus of Moderate Buy, with a price target consensus of $22.
See today’s analyst top recommended stocks >>
The company has a one-year high of $24.07 and a one-year low of $11.09. Currently, American Renal Associates Holdings Inc has an average volume of 169.4K.
TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.
American Renal Associates Holdings, Inc. operates with interest in providing kidney dialysis services. It also offers outpatient and inpatient dialysis treatments for patients suffering from chronic kidney failure.
